Intrathecal Infusion of Bupivacaine With or Without Buprenorphine Relieved Intractable Pain in Three Patients With Vertebral Compression Fractures Caused by Osteoporosis

1999 ◽  
Vol 24 (4) ◽  
pp. 352-357
Author(s):  
Peter O. Dahm ◽  
Petre V. Nitescu ◽  
Lennart K. Appelgren ◽  
Ioan D. Curelaru
2009 ◽  
Vol 8 (1) ◽  
pp. 57-62 ◽  
Author(s):  
Alessio Lovi ◽  
Marco Teli ◽  
Alessandro Ortolina ◽  
Francesco Costa ◽  
Maurizio Fornari ◽  
...  

OBJECTIVE: in a prospective study, we aimed to evaluate the potential use of kyphoplasty (KP) and vertebroplasty (VP) as complementary techniques in the treatment of painful osteoporotic vertebral compression fractures (VCFs). METHODS: after one month of conservative treatment for VCFs, patients with intractable pain were offered treatment with KP or VP according to a treatment algorithm that considers time from fracture (Ät) and amount of Vertebral Body Collapse (VBC). Bone biopsy was obtained intraoperatively to exclude patients affected by malignancy or osteomalacia. RESULTS: hundred and sixty-four patients were included according to the above criteria. Mean age was 67.6 years. Mean followup was 33 months. Ten patients (6.1%) were lost to follow-up and 154 reached the minimum two years follow-up. 118 (69.5%) underwent VP and 36 (30.5%) underwent KP. Complications affected five patients treated with VP, whose one suffered a transient intercostal neuropathy and four a subsequent VCF (two at adjacent level). Results in terms of VAS and Oswestry scores were not different among treatment groups. CONCLUSION: in conclusion, at an average follow-up of almost 3 years from surgical treatment of osteoporotic VCFs, VP and KP show similar good clinical outcomes and appear to be complementary techniques with specific different indications.


2021 ◽  
Vol 9 ◽  
pp. 2050313X2110412
Author(s):  
Peter J Szachowicz ◽  
Thomas J Gross

Vertebral compression fractures remain an important cause of pain and debility. Intractable pain may be approached with vertebral kyphoplasty. We herein present a case of symptomatic pulmonary cement embolism following kyphoplasty. Discovery of a paravertebral cement venogram at the time of this procedure prompted a case series review of our institutional experience with kyphoplasty. We found that cement embolization, whether symptomatic or discovered incidentally, was universally associated with a cement venogram at the site of vertebroplasty. We propose that a cement venogram be viewed as a harbinger of cement pulmonary embolism and this possibility be considered in patients with an existing intracardiac shunt or who present with new respiratory symptoms soon after kyphoplasty.


2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 9535-9535
Author(s):  
B. Georgy ◽  
W. Wong

9535 Background: Percutaneous cement injection procedures (eg vertebroplasty, kyphoplasty) are used successfully to palliate patients with painful osteoporotic vertebral compression fractures (VCFs). When VCFs occur because of malignant lesions however, treatment can be challenging; often by the time symptoms occur, the tumor has extended into the epidural tissue and is associated with posterior cortical disruption. As a result, patients have a higher likelihood of cement extravasation outside the vertebral body, thought to be associated with increased complication risk. This study was to investigate clinical viability and effectiveness of a technique designed to improve control of bone cement placement over standard methods when treating patients with symptomatic VCFs caused by malignancy. Methods: All patients had intractable pain determined to be associated with VCFs caused by metastasized malignancy. The procedure involved using a plasma-mediated radiofrequency-based device to debulk tissue and etch a void within the affected vertebral body and then filling the void and adjacent interstices with bone cement to stabilize the vertebral body and relieve pain. Results: 28 patients (36 vertebral bodies) with various types of metastatic lesions were treated. No evidence of cement extravasation outside the vertebral boundary was detected in 34/36 (94%) cases, even in cases with severe posterior cortical compromise and prominent epidural involvement pre-operatively. In the 2 observed cases, cement extravasation was clinically inconsequential. All treated patients reported marked pain relief. No patients were prevented from continuing other oncologic treatments. Conclusions: Tissue removal to create a void before injecting bone cement into a vertebral body compromised by malignancy may reduce the complication rate observed when injecting cement. This technique may redirect cement away from the spinal canal, notably in cases with posterior cortical defect and epidural extension, while also improving interdigitation of cement and decreasing risk of metastatic embolization. The resulting palliation potentially improves functionality and quality of life during and does not appear to affect the effectiveness of continued oncologic treatment. [Table: see text]


2010 ◽  
Vol 8 (9) ◽  
pp. 1095-1102 ◽  
Author(s):  
Rahul Rastogi ◽  
Trusharth Patel ◽  
Robert A. Swarm

Vertebral compression fractures are common in malignant disease and frequently cause severe back pain. However, management of that pain with conventional medical, radiotherapy, or surgical modalities is often inadequate. Vertebral augmentation techniques, such as vertebroplasty and kyphoplasty, are minimally invasive techniques in which methylmethacrylate bone cement is percutaneously injected into compressed vertebral bodies. Vertebral augmentation often improves mechanical stability of compressed vertebrae, provides pain relief, and may prevent progression of vertebral collapse. Kyphoplasty may provide increased chance for vertebral body height restoration, but the clinical importance of slight change in vertebral body height is unclear. Vertebral augmentation can be used in conjunction with other treatment modalities, and associated pain relief may improve patient tolerance of needed antitumor therapies, such as radiation therapy. Vertebral augmentation is generally very well tolerated, and complications associated with bone cement extravasation beyond the vertebral body have rarely been reported. Because it often provides good to excellent relief of otherwise intractable pain and is generally well tolerated, vertebral augmentation is becoming a first-line agent for management of painful vertebral compression fractures, especially in the setting of malignant disease.


2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 198s-198s
Author(s):  
E.-S. Li ◽  
J.-X. Mu

Background: Recent years, percutaneous vertebroplasty (PVP) has gained wide clinical acceptance as an effective treatment option for patients with intractable pain related to compression fractures of the spine. But little is known about PVP for spinal malignant lesions with epidural involvement in patients with neurologic deficit. Aim: To evaluate the efficacy of PVP for malignant vertebral compression fractures with symptoms of neurologic compression following percutaneous vertebroplasty (PVP), and evaluate the predictive factors for poor outcomes following PVP. Methods: Forty-three patients with malignant vertebral compression fractures with symptoms of neurologic compression were treated with PVP. Patients were classified into 2 groups according to the American Spinal Injury Association (ASIA) impairment scale at the last follow-up. Data were collected and the patients followed-up at 1, 3, 6 and 12 months and yearly after the procedure. Univariate and multivariate analysis was performed to evaluate factors predictive of poor neurologic compression symptoms recovery. Results: PVP were successful in all patients. Full recovery from (n = 2) or improvement of (n = 16) neurologic compression symptoms were achieved in 18 patients (Group A), and no improvement of neurologic compression symptoms in 25 patients (Group A). Univariate analysis showed more PMMA leakage ( P = 0.038) and less PMMA volume injection ( P < 0.001) was associated with the poor symptoms of neurologic compression recovery, and multivariate analysis showed that less PMMA volume injection ( P = 0.004) was an independent predictor for poor symptom of neurologic compression recovery. Conclusion: Our results indicated PVP should not be served as an effective treatment of malignant compression fractures with symptoms of neurologic compression, and less PMMA volume injection was an independent predictor of poor symptom of neurologic compression recovery.


Sign in / Sign up

Export Citation Format

Share Document